52
Participants
Start Date
April 30, 2010
Primary Completion Date
April 30, 2018
Study Completion Date
October 31, 2018
Everolimus (RAD 001)
10mg of Everolimus or Placebo taken by mouth once daily for 1 year or until progression (whichever comes first).
Placebo
University of North Carolina, Chapel Hill
Medical University of South Carolina Hollings Cancer Center, Charleston
University of Miami, Miami
Vanderbilt University, Nashville
University of Mississippi, Jackson
Ohio State University, Columbus
University of Michigan, Ann Arbor
University of Minnesota, Minneapolis
Ingalls Cancer Research Center, Harvey
Northwestern University, Chicago
University of Illinois-Chicago, Chicago
The University of Chicago Medical Center, Chicago
Washington University, St Louis
University of Kansas, Kansas City
Louisianna State University, Shreveport
The University of Texas Medical Branch at Galveston, Galveston
Tufts Medical Center, Boston
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
University of Chicago
OTHER